Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy.

导出 OA

翻译打印收藏纠错

作者： Liang,Leng ^[1] ; Yuebing,Wang ^[2] ; Ningning,He ^[2] ; Di,Wang ^[2] ; Qianjie,Zhao ^[2] ; Guowei,Feng ^[2] ; Weijun,Su ^[2] ; Yang,Xu ^[2] ; Zhongchao,Han ^[3] ; Deling,Kong ^[4] ; Zhen,Cheng ^[5] ; Rong,Xiang ^[2] ; Zongjin,Li ^[6]

作者单位： Nankai University School of Medicine, Tianjin, China; The Key Laboratory of Bioactive Materials, Ministry of Education, Nankai University, College of Life Science, Tianjin, China. ^[1] Nankai University School of Medicine, Tianjin, China. ^[2] State Key Lab of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China. ^[3] The Key Laboratory of Bioactive Materials, Ministry of Education, Nankai University, College of Life Science, Tianjin, China. ^[4] Department of Radiology, Stanford University School of Medicine, Stanford, CA 94305, USA. ^[5] Nankai University School of Medicine, Tianjin, China; The Key Laboratory of Bioactive Materials, Ministry of Education, Nankai University, College of Life Science, Tianjin, China. Electronic address: zongjinli@nankai.edu.cn. ^[6]

关键词 Bioluminescence imaging (BLI)Cancer therapy Mesenchymal stem cells (MSCs)Molecular imaging Near infrared (NIF) imaging